Stock Events

Stock Events

Spectral Medical 

$0.9477
10
-$0.02-2.3% Wednesday 17:00
+$0.00+0.09%Wednesday 21:15After hours

Statistics

Day High
0.97
Day Low
0.97
52W High
1.311
52W Low
0.58
Volume
1,500
Avg. Volume
7,612
Mkt Cap
270.75M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jan 12
$0.12
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

7AugExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.11
-0.07
-0.04
0
Expected EPS
-0.010011264510000001
Actual EPS
N/A

Financials

-683.75%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
3.25MRevenue
-22.2MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EDTXF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cytodyn
CYDY
Mkt Cap356.13M
CytoDyn Inc. focuses on innovative treatments for critical care, which includes sepsis and acute respiratory distress syndrome, areas Spectral Medical is also involved in.
Mesoblast
MESO
Mkt Cap1.86B
Mesoblast Limited specializes in regenerative medicine, including therapies for inflammatory ailments, directly competing with Spectral's treatments for critical care conditions.
Protalix BioTherapeutics
PLX
Mkt Cap178.87M
Protalix BioTherapeutics, Inc. engages in biopharmaceuticals targeting rare diseases, some of which may overlap with Spectral Medical's target conditions.
Mimedx Group
MDXG
Mkt Cap546.63M
MiMedx Group, Inc. offers regenerative biomaterials for inflammation management, competing in the broader market of critical care and regenerative medicine.
Adma Biologics
ADMA
Mkt Cap1.93B
ADMA Biologics, Inc. focuses on the development and commercialization of human plasma and plasma-derived therapeutics, including for immune disorders, potentially competing in Spectral's market.

About

Spectral Medical Inc., together with its associated companies, concentrates on developing and bringing to market healthcare solutions for septic shock and kidney disease patients across North America. The firm offers the Endotoxin Activity Assay (EAA), a quick in vitro diagnostic test that identifies components of gram-negative bacterial cell walls, and Polymyxin B Hemoperfusion (PMX), a therapeutic blood filtration device engineered to eliminate endotoxins from the bloodstream. Additionally, Spectral Medical Inc. produces various specialized biological components, including monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators. These are utilized internally for research and development, as well as supplied to other diagnostic manufacturers. The company is also actively developing a platform dedicated to renal replacement therapy. Originally founded in 1991, the company operated as Spectral Diagnostics Inc. before changing its name to Spectral Medical Inc. in December 2014. Its main corporate office is located in Toronto, Canada.
Show more...
CEO
Mr. Christopher Seto
Employees
29
Country
Canada
ISIN
CA8475771033

Listings

STU
DE
SD4.STU
OTC Link
US
EDTXF
TO
CA
EDT.TO
F
DE
SD4.F

0 Comments

Share your thoughts

FAQ

What is Spectral Medical stock price today?▼
The current price of EDTXF is $0.95 USD — it has decreased by -2.3% in the past 24 hours. Watch Spectral Medical stock price performance more closely on the chart.
What is Spectral Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Spectral Medical stocks are traded under the ticker EDTXF.
Is Spectral Medical stock price growing?▼
EDTXF stock has fallen by -3.88% compared to the previous week, the month change is a -5.8% fall, over the last year Spectral Medical has showed a +50.84% increase.
What is Spectral Medical market cap?▼
Today Spectral Medical has the market capitalization of 270.75M
When is the next Spectral Medical earnings date?▼
Spectral Medical is going to release the next earnings report on August 07, 2026.
What were Spectral Medical earnings last quarter?▼
EDTXF earnings for the last quarter are -0.01 USD per share, whereas the estimation was -0.01 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Spectral Medical revenue for the last year?▼
Spectral Medical revenue for the last year amounts to 3.25M USD.
What is Spectral Medical net income for the last year?▼
EDTXF net income for the last year is -22.2M USD.
Does Spectral Medical pay dividends?▼
Yes, EDTXF dividends are paid semi-annual. The last dividend per share was 0.12 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Spectral Medical have?▼
As of June 25, 2026, the company has 29 employees.
In which sector is Spectral Medical located?▼
Spectral Medical operates in the Health & Wellness sector.
When did Spectral Medical complete a stock split?▼
Spectral Medical has not had any recent stock splits.
Where is Spectral Medical headquartered?▼
Spectral Medical is headquartered in Toronto, Canada.